Evidence map›Paper›PMID 32057785›Full record

ReviewProgress in cardiovascular diseases

Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.

Charles Muiruri, Chris T Longenecker, Eric G Meissner, Nwora Lance Okeke, April C Pettit, Kevin Thomas, Eric Velazquez, Gerald S Bloomfield

Open access · greenAbstract readReview
In one paragraph

Review in Progress in cardiovascular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Incidence of Statin Initiation Among People With and Without HIV in the United States: A Prospective Observational Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025 · on this map
    Observational
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 1 country.

Charles MuiruriDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA; Duke Global Health Institute, Duke University, Durham, NC, USA. Electronic address: charles.muiruri@duke.edu.
Chris T LongeneckerDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Eric G MeissnerDivision of Infectious Diseases, Medical University of South Carolina, Charleston, SC, USA.
Nwora Lance OkekeDepartment of Medicine, Duke University Medical Center NC, USA.
April C PettitSchool of Medicine, Vanderbilt University, Nashville, TN, USA.
Kevin ThomasDepartment of Medicine, Duke University Medical Center NC, USA; Duke Clinical Research Institute, USA.
Eric VelazquezSchool of Medicine, Yale University, New Haven, CT, USA.
Gerald S BloomfieldDuke Global Health Institute, Duke University, Durham, NC, USA; Department of Medicine, Duke University Medical Center NC, USA; Duke Clinical Research Institute, USA.
Clinical Research Institute · USDuke Institute for Health Innovation · USDuke Medical Center · USDuke University · USMedical University of South Carolina · USUniversity School · USVanderbilt University · USYale University · US

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI GEORGIA Doris TOMARAS · 2005 to 2026
$50.5M
Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Stephany Norah Duda · 2015 to 2026
$27.5M
The role of SMAD1 and SATB2 in colon patterningP20GM130457 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI STEPHEN A DUNCAN · 2020 to 2026
$18.7M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
Assess and Adapt to the Impact of COVID-19 on CVD Self Management and Prevention Care in Adults Living with HIV (AAIM-High)U01HL142099 · NHLBI · UNIVERSITY OF WASHINGTON · PI BOSWORTH, HAYDEN B, LONGENECKER, CHRIS TODD · 2018 to 2021
$4.8M
Pathways to cardiovascular disease prevention and impact of specialty referral in under-represented racial/ethnic minorities with HIVR01MD013493 · NIMHD · DUKE UNIVERSITY · PI BLOOMFIELD, GERALD SAMUEL · 2018 to 2022
$3.3M
Multi-level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider VisitsR01MH113438 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PETTIT, APRIL · 2018 to 2020
$1.3M
A Clinic-Based Behavioral Intervention to Reduce Cardiovascular Disease Risk in Persons Living with HIVK23HL137611 · NHLBI · DUKE UNIVERSITY · PI OKEKE, NWORA LANCE · 2018 to 2022
$895k
HSR&D Senior Research Career Scientist AwardIK6HX003161 · VA · DURHAM VA MEDICAL CENTER · PI Hayden B Bosworth · 2020 to 2026
–
HSRD VA IK6 HX003161NHLBI NIH HHS K23 HL137611NHLBI NIH HHS U01 HL142099NIAID NIH HHS P30 AI064518NIAID NIH HHS P30 AI110527NIDDK NIH HHS P30 DK123704NIGMS NIH HHS P20 GM130457NIMHD NIH HHS R01 MD013493
6 · The paper itself

Abstract

Despite developments to improve health in the United States, racial and ethnic disparities persist. These disparities have profound impact on the wellbeing of historically marginalized racial and ethnic groups. This narrative review explores disparities by race in people living with cardiovascular disease (CVD) and the Human Immunodeficiency Virus (HIV). We discuss selected common social determinants of health for both of these conditions which include; regional historical policies, incarceration, and neighborhood effects. Data on racial disparities for persons living with comorbid HIV and CVD are lacking. We found few published articles (n = 7) describing racial disparities for persons living with both comorbid HIV and CVD. Efforts to reduce CVD morbidity in historically marginalized racial and ethnic groups with HIV must address participation in clinical research, social determinants of health and translation of research into clinical practice.

Indexed as

Health Status DisparitiesHIV Long-Term SurvivorsPreventive Health ServicesSocial MarginalizationVulnerable PopulationsAnti-HIV AgentsCardiovascular DiseasesComorbidityHealthcare DisparitiesHIV InfectionsHumansPrognosisProtective FactorsRace FactorsRisk AssessmentRisk FactorsAnti-HIV AgentsCardiovascular diseaseHistorically marginalized racial and ethnic groupsHIVPeople living with HIVRacial disparities

Identifiers

PMID32057785
PMCPMC7237291
OpenAlexW3006276551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.